NCT02472314View on ClinicalTrials.gov

Exparel for Postoperative Pain Management in Shoulder Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Fracture of Shoulder and Upper Arm
Interventions
DRUG

1.3% Liposomal Bupivacaine

local tissue infiltration of Liposomal Bupivacaine during surgery

DRUG

0.125% Bupivacaine

Continues nerve block with Bupivacaine during surgery and postoperatively

Trial Locations (1)

48124

Wayne State University Physician Group, Dearborn

All Listed Sponsors
lead

Wayne State University

OTHER

NCT02472314 - Exparel for Postoperative Pain Management in Shoulder Surgery | Biotech Hunter | Biotech Hunter